|

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

RECRUITINGSponsored by Ann & Robert H Lurie Children's Hospital of Chicago
Actively Recruiting
SponsorAnn & Robert H Lurie Children's Hospital of Chicago
Started2019-08-14
Est. completion2029-08-14
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05120518

Summary

The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology)
* Signed consent for post mortem tissue donation and autopsy

Exclusion Criteria:

* Signed consent for post mortem tissue donation and autopsy not obtained

Conditions2

CancerPediatric Cancer

Locations1 site

Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611
Angela Waanders, MD312-227-4090awaanders@luriechildrens.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.